Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Current Deferred Tax Assets (2016 - 2017)

Ovid Therapeutics filings provide 2 years of Current Deferred Tax Assets readings, the most recent being $1.9 million for Q1 2017.

  • Quarterly Current Deferred Tax Assets changed N/A to $1.9 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2017, changed N/A year-over-year, with the annual reading at $242673.0 for FY2016, N/A changed from the prior year.
  • Current Deferred Tax Assets hit $1.9 million in Q1 2017 for Ovid Therapeutics, up from $242673.0 in the prior quarter.
  • Across five years, Current Deferred Tax Assets topped out at $1.9 million in Q1 2017 and bottomed at $242673.0 in Q4 2016.